Actively Recruiting

Phase Not Applicable
Age: 17Years - 25Years
FEMALE
ID06777940

Effects of Kegel Exercises with and without Myokinetic Active Release of Trigger Points on Pain, Fatigue, and Quality of Life in Primary Dysmenorrhea

Led by Riphah International University · Updated on 2025-01-16

50

Participants Needed

2

Research Sites

58 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating treatments for primary dysmenorrhea, a condition causing painful menstrual cramps, focusing on young women aged 17 to 25. The study aims to compare the effects of Kegel exercises alone versus Kegel exercises combined with myokinetic active release therapy targeting trigger points in specific muscles. This research addresses the gap in evidence about whether myokinetic therapy can improve outcomes related to pain, fatigue, and quality of life for females with primary dysmenorrhea. Participants receive a combination of pelvic floor muscle strengthening through Kegel exercises and myokinetic active release targeting the quadratus lumborum, rectus abdominis, and gluteus medius muscles. The exercise protocol involves holding and relaxing pelvic floor muscles for 3 to 5 seconds in sets of 30 repetitions per session, alongside passive myokinetic therapy applying sustained pressure to release muscle trigger points. The treatment is carefully administered with patients lying down and following a structured rest period between sets. Throughout the study, researchers will measure pain levels, fatigue severity, and quality of life before starting the intervention and after eight weeks. Pain is assessed using a numerical rating scale, fatigue with the Fatigue Severity Scale, and quality of life with the SF-36 questionnaire. Participants will be monitored to evaluate the impact of these treatments on their symptoms and daily functioning during this eight-week period.

CONDITIONS

Official Title

Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea

Who Can Participate

Age: 17Years - 25Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 17-25 years
  • Diagnosed cases of dysmenorrhea
  • Trigger points in rectus abdominis, quadratus lumborum, and gluteus medius muscles
  • Regular menstrual cycles of 21-35 days lasting 3-7 days
Not Eligible

You will not qualify if you...

  • Use of oral contraceptives for menstrual irregularity
  • Other gynecological diseases such as fibroids or endometriosis
  • Use of analgesic medications
  • Conditions like endometrial polyps, pelvic infections, use of intrauterine device (IUD), or venous congestion in internal genital organs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Major balqees maternity home

Lahore, Punjab Province, Pakistan, 53201

Actively Recruiting

2

Major Balqees Maternity Home Clinic

Lahore, Punjab Province, Pakistan

Actively Recruiting

Loading map...

Research Team

I

imran NA amjad, phd

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here